
Evelyn Mei Huang
Examiner (ID: 5025)
| Most Active Art Unit | 1625 |
| Art Unit(s) | 1203, 1625, 3991, 1612 |
| Total Applications | 1346 |
| Issued Applications | 989 |
| Pending Applications | 168 |
| Abandoned Applications | 189 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 979110
[patent_doc_number] => 06930114
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-08-16
[patent_title] => 'Pyrrolo (2.1a)dihydroisoquinolines and their use as phosphodiesterase 10a inhibitors'
[patent_app_type] => utility
[patent_app_number] => 10/451707
[patent_app_country] => US
[patent_app_date] => 2001-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13843
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/930/06930114.pdf
[firstpage_image] =>[orig_patent_app_number] => 10451707
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/451707 | Pyrrolo (2.1a)dihydroisoquinolines and their use as phosphodiesterase 10a inhibitors | Dec 3, 2001 | Issued |
Array
(
[id] => 1298236
[patent_doc_number] => 06627636
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-09-30
[patent_title] => 'HMG-CoA reductase inhibitors and method'
[patent_app_type] => B2
[patent_app_number] => 10/007407
[patent_app_country] => US
[patent_app_date] => 2001-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20929
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/627/06627636.pdf
[firstpage_image] =>[orig_patent_app_number] => 10007407
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/007407 | HMG-CoA reductase inhibitors and method | Dec 3, 2001 | Issued |
Array
(
[id] => 1360340
[patent_doc_number] => 06573272
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-06-03
[patent_title] => 'Antibacterial compounds'
[patent_app_type] => B1
[patent_app_number] => 09/980369
[patent_app_country] => US
[patent_app_date] => 2001-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9717
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 132
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/573/06573272.pdf
[firstpage_image] =>[orig_patent_app_number] => 09980369
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/980369 | Antibacterial compounds | Nov 27, 2001 | Issued |
Array
(
[id] => 1024883
[patent_doc_number] => 06884807
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-04-26
[patent_title] => '3-substituted quinuclidines and their use as nicotinic agonists'
[patent_app_type] => utility
[patent_app_number] => 10/416268
[patent_app_country] => US
[patent_app_date] => 2001-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7585
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 123
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/884/06884807.pdf
[firstpage_image] =>[orig_patent_app_number] => 10416268
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/416268 | 3-substituted quinuclidines and their use as nicotinic agonists | Nov 27, 2001 | Issued |
Array
(
[id] => 5923333
[patent_doc_number] => 20020115679
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-22
[patent_title] => 'Novel farnesyl protein transferase inhibitors'
[patent_app_type] => new
[patent_app_number] => 09/995156
[patent_app_country] => US
[patent_app_date] => 2001-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4325
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0115/20020115679.pdf
[firstpage_image] =>[orig_patent_app_number] => 09995156
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/995156 | Farnesyl protein transferase inhibitors | Nov 26, 2001 | Issued |
Array
(
[id] => 1597089
[patent_doc_number] => 06492513
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-12-10
[patent_title] => 'Method for separating analogous organic compounds'
[patent_app_type] => B1
[patent_app_number] => 09/926611
[patent_app_country] => US
[patent_app_date] => 2001-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 2615
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 117
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/492/06492513.pdf
[firstpage_image] =>[orig_patent_app_number] => 09926611
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/926611 | Method for separating analogous organic compounds | Nov 25, 2001 | Issued |
Array
(
[id] => 6048662
[patent_doc_number] => 20020169155
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-11-14
[patent_title] => ' Chemokine receptor anagonists and methods of use therefor'
[patent_app_type] => new
[patent_app_number] => 09/989086
[patent_app_country] => US
[patent_app_date] => 2001-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 63
[patent_figures_cnt] => 63
[patent_no_of_words] => 62218
[patent_no_of_claims] => 82
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0169/20020169155.pdf
[firstpage_image] =>[orig_patent_app_number] => 09989086
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/989086 | Chemokine receptor anagonists and methods of use therefor | Nov 20, 2001 | Abandoned |
Array
(
[id] => 1467437
[patent_doc_number] => 06458833
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-10-01
[patent_title] => 'Organometallic complex'
[patent_app_type] => B1
[patent_app_number] => 09/989768
[patent_app_country] => US
[patent_app_date] => 2001-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3097
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/458/06458833.pdf
[firstpage_image] =>[orig_patent_app_number] => 09989768
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/989768 | Organometallic complex | Nov 19, 2001 | Issued |
Array
(
[id] => 6131565
[patent_doc_number] => 20020077340
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-06-20
[patent_title] => 'Pyridone inhibitors of fatty acid binding protein and method'
[patent_app_type] => new
[patent_app_number] => 09/989212
[patent_app_country] => US
[patent_app_date] => 2001-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10803
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0077/20020077340.pdf
[firstpage_image] =>[orig_patent_app_number] => 09989212
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/989212 | Pyridone inhibitors of fatty acid binding protein and method | Nov 19, 2001 | Issued |
Array
(
[id] => 5859922
[patent_doc_number] => 20020123506
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-05
[patent_title] => '7-Heterocyclyl quinoline and thieno(2,3-b)pyridine derivatives useful as antagonists of gonadotropin releasing hormone'
[patent_app_type] => new
[patent_app_number] => 09/992785
[patent_app_country] => US
[patent_app_date] => 2001-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7376
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0123/20020123506.pdf
[firstpage_image] =>[orig_patent_app_number] => 09992785
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/992785 | 7-heterocyclyl quinoline and thieno2,3-byridine derivatives useful as antagonists of gonadotropin releasing hormone | Nov 13, 2001 | Issued |
Array
(
[id] => 6083086
[patent_doc_number] => 20020082419
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-06-27
[patent_title] => '2,4-pentadienoic acid derivatives having retinoid-like biological activity'
[patent_app_type] => new
[patent_app_number] => 10/012735
[patent_app_country] => US
[patent_app_date] => 2001-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15453
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0082/20020082419.pdf
[firstpage_image] =>[orig_patent_app_number] => 10012735
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/012735 | 2,4-pentadienoic acid derivatives having retinoid-like biological activity | Nov 4, 2001 | Abandoned |
| 09/869862 | IMIDAZO{4,5-C}-PYRIDENE-4-ON-DERIVATIVES | Nov 4, 2001 | Abandoned |
Array
(
[id] => 5845332
[patent_doc_number] => 20020132802
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-19
[patent_title] => 'Cytoprotective polycyclic compounds'
[patent_app_type] => new
[patent_app_number] => 10/008567
[patent_app_country] => US
[patent_app_date] => 2001-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 12041
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0132/20020132802.pdf
[firstpage_image] =>[orig_patent_app_number] => 10008567
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/008567 | Cytoprotective polycyclic compounds | Nov 4, 2001 | Abandoned |
Array
(
[id] => 6381660
[patent_doc_number] => 20020119981
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-29
[patent_title] => 'Novel N-substituted urea inhibitors of farnesyl-protein transferase'
[patent_app_type] => new
[patent_app_number] => 10/004612
[patent_app_country] => US
[patent_app_date] => 2001-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14346
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0119/20020119981.pdf
[firstpage_image] =>[orig_patent_app_number] => 10004612
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/004612 | N-substituted urea inhibitors of farnesyl-protein transferase | Oct 31, 2001 | Issued |
Array
(
[id] => 1597131
[patent_doc_number] => 06492521
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2002-12-10
[patent_title] => 'Hindered amine light stabilizers based on multi-functional carbonyl compounds and methods of making same'
[patent_app_type] => B2
[patent_app_number] => 10/045333
[patent_app_country] => US
[patent_app_date] => 2001-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30163
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 307
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/492/06492521.pdf
[firstpage_image] =>[orig_patent_app_number] => 10045333
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/045333 | Hindered amine light stabilizers based on multi-functional carbonyl compounds and methods of making same | Oct 24, 2001 | Issued |
Array
(
[id] => 6381352
[patent_doc_number] => 20020119956
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-29
[patent_title] => 'Methods and compositions for inhibition of angiogenesis with phthaloyl glutamic acid derivatives'
[patent_app_type] => new
[patent_app_number] => 10/001183
[patent_app_country] => US
[patent_app_date] => 2001-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6467
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0119/20020119956.pdf
[firstpage_image] =>[orig_patent_app_number] => 10001183
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/001183 | Methods and compositions for inhibition of angiogenesis with phthaloyl glutamic acid derivatives | Oct 23, 2001 | Abandoned |
Array
(
[id] => 5908166
[patent_doc_number] => 20020143019
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-03
[patent_title] => '2-aminoalkylaminoquinolines as dopamine D4 ligands'
[patent_app_type] => new
[patent_app_number] => 10/038198
[patent_app_country] => US
[patent_app_date] => 2001-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5819
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0143/20020143019.pdf
[firstpage_image] =>[orig_patent_app_number] => 10038198
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/038198 | 2-aminoalkylaminoquinolines as dopamine D4 ligands | Oct 22, 2001 | Issued |
Array
(
[id] => 6413630
[patent_doc_number] => 20020183316
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-12-05
[patent_title] => 'Amidoalkyl-piperidine and amidoalkyl-piperazine derivatives useful for the treatment of nervous system disorders'
[patent_app_type] => new
[patent_app_number] => 10/001725
[patent_app_country] => US
[patent_app_date] => 2001-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26000
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 1
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0183/20020183316.pdf
[firstpage_image] =>[orig_patent_app_number] => 10001725
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/001725 | Amidoalkyl-piperidine and amidoalkyl-piperazine derivatives useful for the treatment of nervous system disorders | Oct 21, 2001 | Abandoned |
Array
(
[id] => 1108022
[patent_doc_number] => 06809106
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-10-26
[patent_title] => 'Quinoline derivatives as inhibitors of MEK enzymes'
[patent_app_type] => B1
[patent_app_number] => 09/959005
[patent_app_country] => US
[patent_app_date] => 2001-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14198
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/809/06809106.pdf
[firstpage_image] =>[orig_patent_app_number] => 09959005
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/959005 | Quinoline derivatives as inhibitors of MEK enzymes | Oct 16, 2001 | Issued |
Array
(
[id] => 5923335
[patent_doc_number] => 20020115680
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-22
[patent_title] => 'Anticholinergics which may be used as medicaments as well as processes for preparing them'
[patent_app_type] => new
[patent_app_number] => 09/976950
[patent_app_country] => US
[patent_app_date] => 2001-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9807
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0115/20020115680.pdf
[firstpage_image] =>[orig_patent_app_number] => 09976950
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/976950 | Anticholinergics which may be used as medicaments as well as processes for preparing them | Oct 10, 2001 | Issued |